“We think you may be at risk of a genetic disease”. Should direct-to-consumer genetic testing companies contact at-risk relatives?

By Philip E Baker and Jordan A Parsons. Direct-to-consumer (DTC) genetic testing is becoming increasingly popular. However, with genetic testing comes the possibility of discovering mutations that confer increased risk of genetic diseases not only to the tested individual (the proband), but also their genetic relatives. This raises the challenging ethical question of what should […]

Read More…

Alexa, does this look infected? – We need to talk about safely regulating the digitisation of healthcare, now.

By Catriona McMillan. The sale of health technologies for personal use has boomed in the past few years. At-home access to health information, and the means to track one’s health stats, have been criticised for unnecessarily increasing pressure on NHS services, and in some cases risking user safety. Perhaps surprisingly, however, most of these technologies […]

Read More…

It is time the law stopped incentivising confidentiality: bringing duties of care more in line with professional guidance

By Michael Fay and Edward Dove ABC v St George’s Healthcare (2017) is an important legal decision, and its return to court in November 2019 will be no less significant for doctors’ duties of care. Currently, a doctor is subject to a duty of care to their patient. A doctor also has a corresponding duty […]

Read More…

Privacy: Don’t Get Over It

By Elias Aboujaoude Account hacks. Revenge porn. Identity theft. Cyberstalking. Psychographic targeting. Facial recognition. Government surveillance. It’s enough to give up and agree with the devastatingly prescient remark from 1999 by the founder of Sun Microsystems: “You have zero privacy anyway. Get over it.” In a post-privacy world, victims of technology-enabled privacy violations look to […]

Read More…